XML 23 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
IPO
Private Placement
Series A Redeemable
Convertible Preferred
Stock
Common Stock
Common Stock
IPO
Common Stock
Private Placement
Additional
Paid-In
Capital
Additional
Paid-In
Capital
IPO
Additional
Paid-In
Capital
Private Placement
Accumulated
Deficit
Accumulated
Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated
Other
Comprehensive
(loss) Income
Beginning balance, shares at Dec. 31, 2018         23,081 123,617                
Beginning balance at Dec. 31, 2018 $ (556,535) $ 996     $ 70,906 $ 124     $ 92,201     $ (649,256) $ 996 $ 396
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock upon exercise of stock options (in shares)           1,029                
Issuance of common stock upon exercise of stock options 194         $ 1     193          
Issuance of common stock upon vesting of restricted stock awards (in shares)           263                
Shares surrendered for settlement of minimum statutory tax withholdings (in shares)           (357)                
Shares surrendered for settlement of minimum statutory tax withholdings (3,784)               (3,784)          
Stock-based compensation 5,287               5,287          
Net issuance and repayments of full recourse notes receivable (3)               (3)          
Repurchase and retirement of common stock (in shares)           (170)                
Repurchase and retirement of common stock (1,535)                     (1,535)    
Repurchase of vested stock options and restricted stock units (1,953)                     (1,953)    
Special dividends (978)               (978)          
Other comprehensive income (loss) (6,123)                         (6,123)
Net (loss) income 7,443                     7,443    
Ending balance, shares at Dec. 31, 2019         23,081 124,382                
Ending balance at Dec. 31, 2019 (556,991)       $ 70,906 $ 125     92,916     (644,305)   (5,727)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock upon exercise of stock options (in shares)           1,270                
Issuance of common stock upon exercise of stock options 600         $ 1     599          
Issuance of common stock upon vesting of restricted stock awards (in shares)           245                
Shares surrendered for settlement of minimum statutory tax withholdings (in shares)           (371)                
Shares surrendered for settlement of minimum statutory tax withholdings (3,825)               (3,825)          
Stock-based compensation 12,940               12,940          
Net issuance and repayments of full recourse notes receivable (8)               (8)          
Repurchase and retirement of common stock (in shares)           (489)                
Repurchase and retirement of common stock (4,939)                     (4,939)    
Special dividends (205)               (205)          
Other comprehensive income (loss) (8,100)                         (8,100)
Net (loss) income 9,896                     9,896    
Ending balance, shares at Dec. 31, 2020         23,081 125,037                
Ending balance at Dec. 31, 2020 $ (550,632)       $ 70,906 $ 126     102,417     (639,348)   (13,827)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock upon exercise of stock options (in shares) 831         831                
Issuance of common stock upon exercise of stock options $ 534               534          
Issuance of common stock upon vesting of restricted stock awards and ESPP 1,245         $ 1     1,244          
Issuance of common stock upon vesting of restricted stock awards (in shares)           938                
Shares surrendered for settlement of minimum statutory tax withholdings (in shares)           (87)                
Shares surrendered for settlement of minimum statutory tax withholdings (2,342)               (2,342)          
Stock-based compensation 113,270               113,270          
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares)         (23,081) 46,162                
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering 70,906       $ (70,906) $ 46     70,860          
Issuance of common stock (in shares)             21,989 3,214            
Issuance of common stock     $ 581,833 $ 85,050     $ 22 $ 3   $ 581,811 $ 85,047      
Stock issuance costs (5,636)               (5,636)          
Net issuance and repayments of full recourse notes receivable 43               43          
Special dividends (88)               (88)          
Other comprehensive income (loss) 12,032                         12,032
Net (loss) income (108,664)                     (108,664)    
Ending balance, shares at Dec. 31, 2021         0 198,084                
Ending balance at Dec. 31, 2021 $ 197,551       $ 0 $ 198     $ 947,160     $ (748,012)   $ (1,795)